世界のOTC胃腸薬市場2022年:市場規模予測(~2028年)

■ 英語タイトル:Global OTC Gastrointestinal Products Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート(データ管理コード:GIR22NO19499)■ 発行会社/調査会社:GlobalInfoResearch
■ 商品コード:GIR22NO19499
■ 発行日:2022年11月(※2025年版があります。お問い合わせください。)
■ 調査対象地域:グローバル
■ 産業分野:医薬品
■ ページ数:91
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(注文後2-3日)
■ 販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥528,960見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,220 ⇒換算¥793,440見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,057,920見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[世界のOTC胃腸薬市場2022年:市場規模予測(~2028年)]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

OTC胃腸薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のOTC胃腸薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx%の成長率で成長すると予想されます。

OTC胃腸薬市場は種類と用途によって区分されます。2017年~2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・H2受容体拮抗薬、プロトンポンプ阻害薬(PPI)

用途別セグメントは次のように区分されます。
・病院薬局、ドラッグストア、小売店、EC

世界のOTC胃腸薬市場の主要な市場プレーヤーは以下のとおりです。
・GlaxoSmithKline、Merck、Novartis、Bayer、Pfizer、Bristol-Myers Squibb

地域別セグメントは次の地域・国をカバーします。
・北米(米国、カナダ、メキシコ)
・ヨーロッパ(ドイツ、フランス、イギリス、ロシア、イタリア)
・アジア太平洋(日本、中国、韓国、インド、東南アジア、オーストラリア)
・南アメリカ(ブラジル、アルゼンチン、コロンビア)
・中東およびアフリカ(サウジアラビア、UAE、エジプト、南アフリカ)

本調査レポートの内容は計15章あります。
・第1章では、OTC胃腸薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なOTC胃腸薬メーカーの企業概要、2019年~2022年までのOTC胃腸薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なOTC胃腸薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年~2028年までの地域別OTC胃腸薬の販売量、売上、成長性を示しています。
・第5、6章では、2017年~2028年までのOTC胃腸薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年~2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年~2028年までの主要地域でのOTC胃腸薬市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびOTC胃腸薬の産業チェーンを掲載しています。
・第13、14、15章では、OTC胃腸薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- OTC胃腸薬の概要
- 種類別分析(2017年vs2021年vs2028年):H2受容体拮抗薬、プロトンポンプ阻害薬(PPI)
- 用途別分析(2017年vs2021年vs2028年):病院薬局、ドラッグストア、小売店、EC
- 世界のOTC胃腸薬市場規模・予測
- 世界のOTC胃腸薬生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報(企業概要、製品概要、販売量、価格、売上)
- GlaxoSmithKline、Merck、Novartis、Bayer、Pfizer、Bristol-Myers Squibb
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年:H2受容体拮抗薬、プロトンポンプ阻害薬(PPI)
・用途別分析2017年-2028年:病院薬局、ドラッグストア、小売店、EC
・OTC胃腸薬の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模:アメリカ、カナダ、メキシコなど
・OTC胃腸薬のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模:ドイツ、イギリス、フランス、ロシア、イタリアなど
・OTC胃腸薬のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模:中国、日本、韓国、インド、東南アジア、オーストラリアなど
・OTC胃腸薬の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模:ブラジル、アルゼンチンなど
・OTC胃腸薬の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模:サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The OTC Gastrointestinal Products market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global OTC Gastrointestinal Products market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital Pharmacies accounting for % of the OTC Gastrointestinal Products global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While H2 Receptor Antagonists segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of OTC Gastrointestinal Products include GlaxoSmithKline, Merck, Novartis, Bayer, and Pfizer, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
OTC Gastrointestinal Products market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
H2 Receptor Antagonists
Proton Pump Inhibitors (PPIs)
Market segment by Application can be divided into
Hospital Pharmacies
Drug Stores
Retail Stores
E-Commerce
The key market players for global OTC Gastrointestinal Products market are listed below:
GlaxoSmithKline
Merck
Novartis
Bayer
Pfizer
Bristol-Myers Squibb
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe OTC Gastrointestinal Products product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of OTC Gastrointestinal Products, with price, sales, revenue and global market share of OTC Gastrointestinal Products from 2019 to 2022.
Chapter 3, the OTC Gastrointestinal Products competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the OTC Gastrointestinal Products breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and OTC Gastrointestinal Products market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of OTC Gastrointestinal Products.
Chapter 13, 14, and 15, to describe OTC Gastrointestinal Products sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次(コンテンツ)***

1 Market Overview
1.1 OTC Gastrointestinal Products Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global OTC Gastrointestinal Products Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 H2 Receptor Antagonists
1.2.3 Proton Pump Inhibitors (PPIs)
1.3 Market Analysis by Application
1.3.1 Overview: Global OTC Gastrointestinal Products Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital Pharmacies
1.3.3 Drug Stores
1.3.4 Retail Stores
1.3.5 E-Commerce
1.4 Global OTC Gastrointestinal Products Market Size & Forecast
1.4.1 Global OTC Gastrointestinal Products Sales in Value (2017 & 2021 & 2028)
1.4.2 Global OTC Gastrointestinal Products Sales in Volume (2017-2028)
1.4.3 Global OTC Gastrointestinal Products Price (2017-2028)
1.5 Global OTC Gastrointestinal Products Production Capacity Analysis
1.5.1 Global OTC Gastrointestinal Products Total Production Capacity (2017-2028)
1.5.2 Global OTC Gastrointestinal Products Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 OTC Gastrointestinal Products Market Drivers
1.6.2 OTC Gastrointestinal Products Market Restraints
1.6.3 OTC Gastrointestinal Products Trends Analysis
2 Manufacturers Profiles
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business
2.1.3 GlaxoSmithKline OTC Gastrointestinal Products Product and Services
2.1.4 GlaxoSmithKline OTC Gastrointestinal Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck OTC Gastrointestinal Products Product and Services
2.2.4 Merck OTC Gastrointestinal Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis OTC Gastrointestinal Products Product and Services
2.3.4 Novartis OTC Gastrointestinal Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Bayer
2.4.1 Bayer Details
2.4.2 Bayer Major Business
2.4.3 Bayer OTC Gastrointestinal Products Product and Services
2.4.4 Bayer OTC Gastrointestinal Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business
2.5.3 Pfizer OTC Gastrointestinal Products Product and Services
2.5.4 Pfizer OTC Gastrointestinal Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Bristol-Myers Squibb
2.6.1 Bristol-Myers Squibb Details
2.6.2 Bristol-Myers Squibb Major Business
2.6.3 Bristol-Myers Squibb OTC Gastrointestinal Products Product and Services
2.6.4 Bristol-Myers Squibb OTC Gastrointestinal Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 OTC Gastrointestinal Products Breakdown Data by Manufacturer
3.1 Global OTC Gastrointestinal Products Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global OTC Gastrointestinal Products Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in OTC Gastrointestinal Products
3.4 Market Concentration Rate
3.4.1 Top 3 OTC Gastrointestinal Products Manufacturer Market Share in 2021
3.4.2 Top 6 OTC Gastrointestinal Products Manufacturer Market Share in 2021
3.5 Global OTC Gastrointestinal Products Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and OTC Gastrointestinal Products Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global OTC Gastrointestinal Products Market Size by Region
4.1.1 Global OTC Gastrointestinal Products Sales in Volume by Region (2017-2028)
4.1.2 Global OTC Gastrointestinal Products Revenue by Region (2017-2028)
4.2 North America OTC Gastrointestinal Products Revenue (2017-2028)
4.3 Europe OTC Gastrointestinal Products Revenue (2017-2028)
4.4 Asia-Pacific OTC Gastrointestinal Products Revenue (2017-2028)
4.5 South America OTC Gastrointestinal Products Revenue (2017-2028)
4.6 Middle East and Africa OTC Gastrointestinal Products Revenue (2017-2028)
5 Market Segment by Type
5.1 Global OTC Gastrointestinal Products Sales in Volume by Type (2017-2028)
5.2 Global OTC Gastrointestinal Products Revenue by Type (2017-2028)
5.3 Global OTC Gastrointestinal Products Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global OTC Gastrointestinal Products Sales in Volume by Application (2017-2028)
6.2 Global OTC Gastrointestinal Products Revenue by Application (2017-2028)
6.3 Global OTC Gastrointestinal Products Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America OTC Gastrointestinal Products Sales by Type (2017-2028)
7.2 North America OTC Gastrointestinal Products Sales by Application (2017-2028)
7.3 North America OTC Gastrointestinal Products Market Size by Country
7.3.1 North America OTC Gastrointestinal Products Sales in Volume by Country (2017-2028)
7.3.2 North America OTC Gastrointestinal Products Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe OTC Gastrointestinal Products Sales by Type (2017-2028)
8.2 Europe OTC Gastrointestinal Products Sales by Application (2017-2028)
8.3 Europe OTC Gastrointestinal Products Market Size by Country
8.3.1 Europe OTC Gastrointestinal Products Sales in Volume by Country (2017-2028)
8.3.2 Europe OTC Gastrointestinal Products Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific OTC Gastrointestinal Products Sales by Type (2017-2028)
9.2 Asia-Pacific OTC Gastrointestinal Products Sales by Application (2017-2028)
9.3 Asia-Pacific OTC Gastrointestinal Products Market Size by Region
9.3.1 Asia-Pacific OTC Gastrointestinal Products Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific OTC Gastrointestinal Products Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America OTC Gastrointestinal Products Sales by Type (2017-2028)
10.2 South America OTC Gastrointestinal Products Sales by Application (2017-2028)
10.3 South America OTC Gastrointestinal Products Market Size by Country
10.3.1 South America OTC Gastrointestinal Products Sales in Volume by Country (2017-2028)
10.3.2 South America OTC Gastrointestinal Products Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa OTC Gastrointestinal Products Sales by Type (2017-2028)
11.2 Middle East & Africa OTC Gastrointestinal Products Sales by Application (2017-2028)
11.3 Middle East & Africa OTC Gastrointestinal Products Market Size by Country
11.3.1 Middle East & Africa OTC Gastrointestinal Products Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa OTC Gastrointestinal Products Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of OTC Gastrointestinal Products and Key Manufacturers
12.2 Manufacturing Costs Percentage of OTC Gastrointestinal Products
12.3 OTC Gastrointestinal Products Production Process
12.4 OTC Gastrointestinal Products Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 OTC Gastrointestinal Products Typical Distributors
13.3 OTC Gastrointestinal Products Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global OTC Gastrointestinal Products Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global OTC Gastrointestinal Products Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 4. GlaxoSmithKline Major Business
Table 5. GlaxoSmithKline OTC Gastrointestinal Products Product and Services
Table 6. GlaxoSmithKline OTC Gastrointestinal Products Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Merck Basic Information, Manufacturing Base and Competitors
Table 8. Merck Major Business
Table 9. Merck OTC Gastrointestinal Products Product and Services
Table 10. Merck OTC Gastrointestinal Products Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Novartis Basic Information, Manufacturing Base and Competitors
Table 12. Novartis Major Business
Table 13. Novartis OTC Gastrointestinal Products Product and Services
Table 14. Novartis OTC Gastrointestinal Products Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Bayer Basic Information, Manufacturing Base and Competitors
Table 16. Bayer Major Business
Table 17. Bayer OTC Gastrointestinal Products Product and Services
Table 18. Bayer OTC Gastrointestinal Products Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Pfizer Basic Information, Manufacturing Base and Competitors
Table 20. Pfizer Major Business
Table 21. Pfizer OTC Gastrointestinal Products Product and Services
Table 22. Pfizer OTC Gastrointestinal Products Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 24. Bristol-Myers Squibb Major Business
Table 25. Bristol-Myers Squibb OTC Gastrointestinal Products Product and Services
Table 26. Bristol-Myers Squibb OTC Gastrointestinal Products Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Global OTC Gastrointestinal Products Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 28. Global OTC Gastrointestinal Products Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 29. Market Position of Manufacturers in OTC Gastrointestinal Products, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 30. Global OTC Gastrointestinal Products Production Capacity by Company, (K Units): 2020 VS 2021
Table 31. Head Office and OTC Gastrointestinal Products Production Site of Key Manufacturer
Table 32. OTC Gastrointestinal Products New Entrant and Capacity Expansion Plans
Table 33. OTC Gastrointestinal Products Mergers & Acquisitions in the Past Five Years
Table 34. Global OTC Gastrointestinal Products Sales by Region (2017-2022) & (K Units)
Table 35. Global OTC Gastrointestinal Products Sales by Region (2023-2028) & (K Units)
Table 36. Global OTC Gastrointestinal Products Revenue by Region (2017-2022) & (USD Million)
Table 37. Global OTC Gastrointestinal Products Revenue by Region (2023-2028) & (USD Million)
Table 38. Global OTC Gastrointestinal Products Sales by Type (2017-2022) & (K Units)
Table 39. Global OTC Gastrointestinal Products Sales by Type (2023-2028) & (K Units)
Table 40. Global OTC Gastrointestinal Products Revenue by Type (2017-2022) & (USD Million)
Table 41. Global OTC Gastrointestinal Products Revenue by Type (2023-2028) & (USD Million)
Table 42. Global OTC Gastrointestinal Products Price by Type (2017-2022) & (USD/Unit)
Table 43. Global OTC Gastrointestinal Products Price by Type (2023-2028) & (USD/Unit)
Table 44. Global OTC Gastrointestinal Products Sales by Application (2017-2022) & (K Units)
Table 45. Global OTC Gastrointestinal Products Sales by Application (2023-2028) & (K Units)
Table 46. Global OTC Gastrointestinal Products Revenue by Application (2017-2022) & (USD Million)
Table 47. Global OTC Gastrointestinal Products Revenue by Application (2023-2028) & (USD Million)
Table 48. Global OTC Gastrointestinal Products Price by Application (2017-2022) & (USD/Unit)
Table 49. Global OTC Gastrointestinal Products Price by Application (2023-2028) & (USD/Unit)
Table 50. North America OTC Gastrointestinal Products Sales by Country (2017-2022) & (K Units)
Table 51. North America OTC Gastrointestinal Products Sales by Country (2023-2028) & (K Units)
Table 52. North America OTC Gastrointestinal Products Revenue by Country (2017-2022) & (USD Million)
Table 53. North America OTC Gastrointestinal Products Revenue by Country (2023-2028) & (USD Million)
Table 54. North America OTC Gastrointestinal Products Sales by Type (2017-2022) & (K Units)
Table 55. North America OTC Gastrointestinal Products Sales by Type (2023-2028) & (K Units)
Table 56. North America OTC Gastrointestinal Products Sales by Application (2017-2022) & (K Units)
Table 57. North America OTC Gastrointestinal Products Sales by Application (2023-2028) & (K Units)
Table 58. Europe OTC Gastrointestinal Products Sales by Country (2017-2022) & (K Units)
Table 59. Europe OTC Gastrointestinal Products Sales by Country (2023-2028) & (K Units)
Table 60. Europe OTC Gastrointestinal Products Revenue by Country (2017-2022) & (USD Million)
Table 61. Europe OTC Gastrointestinal Products Revenue by Country (2023-2028) & (USD Million)
Table 62. Europe OTC Gastrointestinal Products Sales by Type (2017-2022) & (K Units)
Table 63. Europe OTC Gastrointestinal Products Sales by Type (2023-2028) & (K Units)
Table 64. Europe OTC Gastrointestinal Products Sales by Application (2017-2022) & (K Units)
Table 65. Europe OTC Gastrointestinal Products Sales by Application (2023-2028) & (K Units)
Table 66. Asia-Pacific OTC Gastrointestinal Products Sales by Region (2017-2022) & (K Units)
Table 67. Asia-Pacific OTC Gastrointestinal Products Sales by Region (2023-2028) & (K Units)
Table 68. Asia-Pacific OTC Gastrointestinal Products Revenue by Region (2017-2022) & (USD Million)
Table 69. Asia-Pacific OTC Gastrointestinal Products Revenue by Region (2023-2028) & (USD Million)
Table 70. Asia-Pacific OTC Gastrointestinal Products Sales by Type (2017-2022) & (K Units)
Table 71. Asia-Pacific OTC Gastrointestinal Products Sales by Type (2023-2028) & (K Units)
Table 72. Asia-Pacific OTC Gastrointestinal Products Sales by Application (2017-2022) & (K Units)
Table 73. Asia-Pacific OTC Gastrointestinal Products Sales by Application (2023-2028) & (K Units)
Table 74. South America OTC Gastrointestinal Products Sales by Country (2017-2022) & (K Units)
Table 75. South America OTC Gastrointestinal Products Sales by Country (2023-2028) & (K Units)
Table 76. South America OTC Gastrointestinal Products Revenue by Country (2017-2022) & (USD Million)
Table 77. South America OTC Gastrointestinal Products Revenue by Country (2023-2028) & (USD Million)
Table 78. South America OTC Gastrointestinal Products Sales by Type (2017-2022) & (K Units)
Table 79. South America OTC Gastrointestinal Products Sales by Type (2023-2028) & (K Units)
Table 80. South America OTC Gastrointestinal Products Sales by Application (2017-2022) & (K Units)
Table 81. South America OTC Gastrointestinal Products Sales by Application (2023-2028) & (K Units)
Table 82. Middle East & Africa OTC Gastrointestinal Products Sales by Region (2017-2022) & (K Units)
Table 83. Middle East & Africa OTC Gastrointestinal Products Sales by Region (2023-2028) & (K Units)
Table 84. Middle East & Africa OTC Gastrointestinal Products Revenue by Region (2017-2022) & (USD Million)
Table 85. Middle East & Africa OTC Gastrointestinal Products Revenue by Region (2023-2028) & (USD Million)
Table 86. Middle East & Africa OTC Gastrointestinal Products Sales by Type (2017-2022) & (K Units)
Table 87. Middle East & Africa OTC Gastrointestinal Products Sales by Type (2023-2028) & (K Units)
Table 88. Middle East & Africa OTC Gastrointestinal Products Sales by Application (2017-2022) & (K Units)
Table 89. Middle East & Africa OTC Gastrointestinal Products Sales by Application (2023-2028) & (K Units)
Table 90. OTC Gastrointestinal Products Raw Material
Table 91. Key Manufacturers of OTC Gastrointestinal Products Raw Materials
Table 92. Direct Channel Pros & Cons
Table 93. Indirect Channel Pros & Cons
Table 94. OTC Gastrointestinal Products Typical Distributors
Table 95. OTC Gastrointestinal Products Typical Customers
List of Figures
Figure 1. OTC Gastrointestinal Products Picture
Figure 2. Global OTC Gastrointestinal Products Revenue Market Share by Type in 2021
Figure 3. H2 Receptor Antagonists
Figure 4. Proton Pump Inhibitors (PPIs)
Figure 5. Global OTC Gastrointestinal Products Revenue Market Share by Application in 2021
Figure 6. Hospital Pharmacies
Figure 7. Drug Stores
Figure 8. Retail Stores
Figure 9. E-Commerce
Figure 10. Global OTC Gastrointestinal Products Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 11. Global OTC Gastrointestinal Products Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global OTC Gastrointestinal Products Sales (2017-2028) & (K Units)
Figure 13. Global OTC Gastrointestinal Products Price (2017-2028) & (USD/Unit)
Figure 14. Global OTC Gastrointestinal Products Production Capacity (2017-2028) & (K Units)
Figure 15. Global OTC Gastrointestinal Products Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. OTC Gastrointestinal Products Market Drivers
Figure 17. OTC Gastrointestinal Products Market Restraints
Figure 18. OTC Gastrointestinal Products Market Trends
Figure 19. Global OTC Gastrointestinal Products Sales Market Share by Manufacturer in 2021
Figure 20. Global OTC Gastrointestinal Products Revenue Market Share by Manufacturer in 2021
Figure 21. OTC Gastrointestinal Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 OTC Gastrointestinal Products Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 OTC Gastrointestinal Products Manufacturer (Revenue) Market Share in 2021
Figure 24. Global OTC Gastrointestinal Products Sales Market Share by Region (2017-2028)
Figure 25. Global OTC Gastrointestinal Products Revenue Market Share by Region (2017-2028)
Figure 26. North America OTC Gastrointestinal Products Revenue (2017-2028) & (USD Million)
Figure 27. Europe OTC Gastrointestinal Products Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific OTC Gastrointestinal Products Revenue (2017-2028) & (USD Million)
Figure 29. South America OTC Gastrointestinal Products Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa OTC Gastrointestinal Products Revenue (2017-2028) & (USD Million)
Figure 31. Global OTC Gastrointestinal Products Sales Market Share by Type (2017-2028)
Figure 32. Global OTC Gastrointestinal Products Revenue Market Share by Type (2017-2028)
Figure 33. Global OTC Gastrointestinal Products Price by Type (2017-2028) & (USD/Unit)
Figure 34. Global OTC Gastrointestinal Products Sales Market Share by Application (2017-2028)
Figure 35. Global OTC Gastrointestinal Products Revenue Market Share by Application (2017-2028)
Figure 36. Global OTC Gastrointestinal Products Price by Application (2017-2028) & (USD/Unit)
Figure 37. North America OTC Gastrointestinal Products Sales Market Share by Type (2017-2028)
Figure 38. North America OTC Gastrointestinal Products Sales Market Share by Application (2017-2028)
Figure 39. North America OTC Gastrointestinal Products Sales Market Share by Country (2017-2028)
Figure 40. North America OTC Gastrointestinal Products Revenue Market Share by Country (2017-2028)
Figure 41. United States OTC Gastrointestinal Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada OTC Gastrointestinal Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico OTC Gastrointestinal Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe OTC Gastrointestinal Products Sales Market Share by Type (2017-2028)
Figure 45. Europe OTC Gastrointestinal Products Sales Market Share by Application (2017-2028)
Figure 46. Europe OTC Gastrointestinal Products Sales Market Share by Country (2017-2028)
Figure 47. Europe OTC Gastrointestinal Products Revenue Market Share by Country (2017-2028)
Figure 48. Germany OTC Gastrointestinal Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France OTC Gastrointestinal Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom OTC Gastrointestinal Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia OTC Gastrointestinal Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy OTC Gastrointestinal Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific OTC Gastrointestinal Products Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific OTC Gastrointestinal Products Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific OTC Gastrointestinal Products Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific OTC Gastrointestinal Products Revenue Market Share by Region (2017-2028)
Figure 57. China OTC Gastrointestinal Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan OTC Gastrointestinal Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea OTC Gastrointestinal Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India OTC Gastrointestinal Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia OTC Gastrointestinal Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia OTC Gastrointestinal Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America OTC Gastrointestinal Products Sales Market Share by Type (2017-2028)
Figure 64. South America OTC Gastrointestinal Products Sales Market Share by Application (2017-2028)
Figure 65. South America OTC Gastrointestinal Products Sales Market Share by Country (2017-2028)
Figure 66. South America OTC Gastrointestinal Products Revenue Market Share by Country (2017-2028)
Figure 67. Brazil OTC Gastrointestinal Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina OTC Gastrointestinal Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa OTC Gastrointestinal Products Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa OTC Gastrointestinal Products Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa OTC Gastrointestinal Products Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa OTC Gastrointestinal Products Revenue Market Share by Region (2017-2028)
Figure 73. Turkey OTC Gastrointestinal Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt OTC Gastrointestinal Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia OTC Gastrointestinal Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa OTC Gastrointestinal Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of OTC Gastrointestinal Products in 2021
Figure 78. Manufacturing Process Analysis of OTC Gastrointestinal Products
Figure 79. OTC Gastrointestinal Products Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(GIR22NO19499 )"世界のOTC胃腸薬市場2022年:市場規模予測(~2028年)" (英文:Global OTC Gastrointestinal Products Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。